The efficacy of low-dose tadalafil in patients undergoing hemodialysis with end-stage renal disease

Bolat M. S., Ozer I., Cinar O., Akdeniz E., Aşcı R.

RENAL FAILURE, cilt.39, sa.1, ss.582-587, 2017 (SCI-Expanded, Scopus) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 39 Sayı: 1
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1080/0886022x.2017.1349678
  • Dergi Adı: RENAL FAILURE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.582-587
  • Anahtar Kelimeler: End-stage renal disease, hemodialysis, sexual dysfunction, psychology, QUALITY-OF-LIFE, ERECTILE DYSFUNCTION, TRANSPLANT RECIPIENTS, INTERNATIONAL INDEX, INHIBITOR TADALAFIL, CHRONIC DIALYSIS, MEN, DEPRESSION, MANAGEMENT, HEALTH
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

Background: Erectile dysfunction (ED) is a disorder that is frequently observed in people with chronic kidney disease who undergo hemodialysis (HD). In the context of evidence-based medicine, we aimed to investigate the effect of low-dose tadalafil on sexual function in patients undergoing HD.